1. Home
  2. SXTC vs SKY Comparison

SXTC vs SKY Comparison

Compare SXTC & SKY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXTC
  • SKY
  • Stock Information
  • Founded
  • SXTC 2005
  • SKY 2010
  • Country
  • SXTC China
  • SKY United States
  • Employees
  • SXTC N/A
  • SKY N/A
  • Industry
  • SXTC Biotechnology: Pharmaceutical Preparations
  • SKY Homebuilding
  • Sector
  • SXTC Health Care
  • SKY Consumer Discretionary
  • Exchange
  • SXTC Nasdaq
  • SKY Nasdaq
  • Market Cap
  • SXTC 2.5M
  • SKY N/A
  • IPO Year
  • SXTC 2019
  • SKY N/A
  • Fundamental
  • Price
  • SXTC $0.72
  • SKY $93.87
  • Analyst Decision
  • SXTC
  • SKY Buy
  • Analyst Count
  • SXTC 0
  • SKY 4
  • Target Price
  • SXTC N/A
  • SKY $78.75
  • AVG Volume (30 Days)
  • SXTC 1.4M
  • SKY 385.5K
  • Earning Date
  • SXTC 01-01-0001
  • SKY 10-29-2024
  • Dividend Yield
  • SXTC N/A
  • SKY N/A
  • EPS Growth
  • SXTC N/A
  • SKY N/A
  • EPS
  • SXTC N/A
  • SKY 2.43
  • Revenue
  • SXTC $1,928,497.00
  • SKY $2,187,833,000.00
  • Revenue This Year
  • SXTC N/A
  • SKY $20.80
  • Revenue Next Year
  • SXTC N/A
  • SKY $6.26
  • P/E Ratio
  • SXTC N/A
  • SKY $38.59
  • Revenue Growth
  • SXTC N/A
  • SKY N/A
  • 52 Week Low
  • SXTC $0.53
  • SKY $52.12
  • 52 Week High
  • SXTC $6.39
  • SKY $97.22
  • Technical
  • Relative Strength Index (RSI)
  • SXTC 50.69
  • SKY 55.40
  • Support Level
  • SXTC $0.65
  • SKY $93.25
  • Resistance Level
  • SXTC $0.82
  • SKY $96.71
  • Average True Range (ATR)
  • SXTC 0.09
  • SKY 2.37
  • MACD
  • SXTC 0.03
  • SKY -0.20
  • Stochastic Oscillator
  • SXTC 52.97
  • SKY 48.83

About SXTC China SXT Pharmaceuticals Inc.

China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

Share on Social Networks: